Leal Health
Leal is the leading AI-powered treatment decision support platform that democratizes patient access to cancer treatments
About Leal Health
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to execute patient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn.
Company Facts
- Headquarters
- New York
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00051_00100
- Funding Stage
- early_stage_venture
- Total Funding
- $27,719,988
- Last Funding Type
- series_a
- Last Funding Date
- 2022-02-07
- Website
- leal.health
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Communities, Health Care, Marketplace, SaaS
Social Links
Canonical: https://fsome.com/organization/leal-health-56853 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.